CLOSE| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 20, 2020 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,963 | -- | 396,509 |
| Feb 25, 2019 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 33,071 | -- | 306,564 |
| Sep 21, 2018 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 35,324 | -- | 224,758 |
| Jul 31, 2018 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 14,027 | -- | 224,758 |
| Feb 23, 2017 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 36,156 | -- | 236,487 |
| Feb 13, 2017 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 13,409 | -- | -- |
| Feb 25, 2016 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 36,154 | -- | 212,629 |
| Mar 16, 2015 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 13,125 | -- | 187,339 |
| Feb 25, 2015 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,031 | -- | 182,618 |
| Jan 30, 2015 |
President & CEO
|
President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,612 | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.